Background-Individuals with exaggerated exercise blood pressure (BP) tend to develop future hypertension. It is controversial whether they have higher risk of death from cardiovascular disease (CVD 
B
lood pressure (BP) response to exercise has been studied in relation to incident hypertension. Several studies found that nonhypertensive individuals with exaggerated BP responses during Bruce and ergonomic stress protocols are more likely to develop clinical hypertension compared with those with a normal BP response. [1] [2] [3] Subsequently, several studies examined whether exercise BP in healthy individuals predicts future morbidity and death from cardiovascular disease (CVD), the results of which have varied, depending in part on the stage of exercise when BP was measured.
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Fagard and colleagues 4 first noted that neither submaximal nor maximal exercise BP yielded additive prognostic information over baseline BP for CVD or all-cause mortality in their study of 143 hypertensive men. Contrarily, others found that exaggerated submaximal exercise BP was associated with future CVD death independent of rest BP, [5] [6] [7] although, in many of these studies, the ability of exercise BP to predict death was attenuated once BP was measured at maximum capacity. 5, 7 A recent analysis from the Framingham Offspring Study found that exercise diastolic BP, but not systolic BP, measured at low-level exercise (stage 2 Bruce protocol) was associated with CVD events independent of other risk factors and baseline BP. 8 Given these conflicting data on the association with CVD end points, the American College of Cardiology/American Heart Association guidelines on exercise testing included exercise-induced hypertension as a marker for future clinical hypertension but did not link it with CVD or mortality outcomes. 9 Therefore, the present study sought to evaluate whether exaggerated systolic or diastolic BP attained at low and submaximal exercise was associated with future CVD death in a large population of healthy men and women. We also sought to determine whether exercise BP response provided incremental risk information to baseline BP and other risk factors.
Methods

Study Participants
Participants were derived from the Lipid Research Clinics Prevalence Study, a prospective cohort of North American individuals across 10 geographic locations and diverse socioeconomic and occupational groups, as described previously. 10, 11 Briefly, participants were recruited from selected target populations in North America meant to provide a cross-sectional view by virtue of size and economic and geographic diversity. The populations fell into 3 broad categories: occupational groups, household or residential groups, and parents of school children. Recruited individuals were screened at visit 1 for triglycerides and cholesterol levels. Participants with elevated lipids, as well as an additional random sample of all who participated and subjects with borderline hyperlipidemia, were asked to return for visit 2. In total, the random sample constituted 58.4% of the total study participants. A comprehensive medical history, physical examination, fasting blood samples, resting ECG, and exercise treadmill test were obtained at baseline visit 2 (1972-1976) . Participants were ineligible if pregnant, if they had evidence of current or past myocardial ischemia or coronary artery bypass surgery, if they had baseline systolic BP Ͻ90 or Ͼ200 mm Hg or diastolic BP Ͼ120 mm Hg, or if they were deemed ineligible for exercise testing by the study physicians.
Altogether, 8652 of 13 852 individuals screened underwent baseline exercise tests. Of these, we additionally excluded 1877 individuals to reduce potential confounding by preexisting disease or comorbidity for the following reasons: exercise duration Ͻ1 minute, known or suspected CVD (myocardial infarction, angina, stroke, claudication, heart surgery, congestive heart failure, or digitalis use), baseline age Ͻ30 or Ͼ70 years, treadmill test other than Bruce protocol, and those lost to follow-up (nϭ6). Another 197 individuals were excluded because of missing baseline or exercise BP measurements, resulting in 6578 individuals for this analysis.
Follow-up was until death or December 31, 1995. The primary outcome of this study was CVD death, ascertained with death certificates, interviews with next of kin, medical records, the National Death Index, and the Epidemiology Research Index. All participants gave written informed consent at study enrollment. The Brigham and Women's institutional review board approved the present study. Drs Weiss and Mora had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Exercise Test Protocol
Participants underwent a standard submaximal Bruce protocol treadmill exercise test, 12 which was terminated when a predetermined target heart rate of Ն90% of maximal predicted heart rate for age and physical activity was achieved and maintained for 1 minute or until the end of the stage, or when target heart rate was exceeded by 8 bpm. 10 An ECG was monitored before test initiation, continuously during exercise, and for 6 minutes after exercise. Heart rate was monitored continuously. BP measurements were taken at the end of each 3-minute exercise stage by the cuff technique. Participants were allowed to touch the treadmill for balance but not to pull or lean on it. The test could be terminated early at the discretion of the supervising physicians for significant symptoms, arrhythmias, hemodynamic instability, or ST-segment changes on ECG or if the participant was unwilling or unable to continue.
Baseline and Exercise Test Variables
The mean of 2 BP measurements taken at rest (supine) before exercise was used to define hypertension (systolic BP Ն140 Cox proportional hazards models were used to examine the association of baseline and exercise BP with time to CVD death. We considered 3 levels of adjustment: (1) age and sex, (2) plus non-BP variables (age, sex, diabetes mellitus, low-and high-density lipoprotein [LDL and HDL] cholesterol, triglycerides, smoking, body mass index, and family history), and (3) plus rest BP (for models examining exercise BP). We further adjusted the model with non-BP variables for exercise capacity to account for differences in achieved exercise workload. The proportional hazards assumption was satisfied with the use of Schoenfeld residuals and the natural logarithm of follow-up time.
To examine the additional value of exercise BP according to baseline hypertension, individuals were stratified according to baseline presence or absence of hypertension and evaluated for exercise BP. Similar analyses were performed for participants with baseline prehypertension and normal BP. Statistical tests for interaction between baseline and exercise BP in relation to CVD death were obtained with the use of likelihood ratio tests.
The likelihood ratio 2 statistic was used to evaluate the goodness of fit of predictive models. Model discrimination was examined with the c-index, 15 a generalization of the area under the receiver operating characteristic curve. Risk reclassification was assessed by categorizing the predicted 10-year CVD death risk for each model into 3 categories (Յ2.5%, 2.5% to 10%, and Ͼ10%) or 4 categories (Յ2.5%, 2.5% to 5%, 5% to 10%, and Ͼ10%). We computed the net reclassification improvement (NRI), 16 which compares the shifts in reclassified categories by observed outcome, and the integrated discrimination improvement, 16 which compares the integrals of sensitivity and specificity under 2 models. Because of the fewer number of events among those with normal BP or prehypertension during this 10-year interval, we assessed the NRI and integrated discrimination improvement for the combined group (nonhypertensives).
Results
Baseline Characteristics
The cohort of 6578 asymptomatic study participants was middle-aged (mean age, 46 years), with a large proportion (45%) of women (Table 1) . Of the total, 4844 (74%) had untreated rest BP Ͻ140/90 mm Hg (nonhypertensive). Table 2 shows baseline demographic, clinical, and exercise test characteristics according to categories of Bruce stage 2 BP. Except for regular exercise, which occurred more frequently in increasing quartiles of ExSBP max , the remaining characteristics were similar in Bruce 2 and maximum BP categories regardless of stage of exercise and are thus shown by ExSBP low and ExDBP low in Table 2 . Individuals in increasing categories of ExSBP and ExDBP were older with more prevalent diabetes mellitus, hypertension, and dyslipidemia. Slightly more than half of individuals with baseline hypertension also had ExSBP max Ͼ200 mm Hg (56.5%) and ExSBP low Ͼ180 mm Hg (50.3%). Smoking and a premature family history of coronary disease were somewhat less prevalent in those with highest ExSBP, and smoking was less prevalent in those with the highest ExDBP.
Exercise BP and CVD Death
During a mean follow-up of 20.1Ϯ4.0 years, there were 385 CVD deaths. Kaplan-Meier curves according to maximum (ExSBP max and ExDBP max ) and Bruce stage 2 BP (ExSBP low and ExDBP low ) categories show significant associations with survival free of CVD death ( Figure) , with a wider curve separation noted for systolic compared with diastolic exercise BP curves.
Exercise Systolic BP
In age-and sex-adjusted analyses (Table 3 ), higher levels of systolic BP measured at rest, during Bruce stage 2, and during exercise were associated with increased risk of CVD death. On the basis of hazard ratios (HRs) per 10 mm Hg-increments in systolic BP, the magnitude of association was stronger for rest systolic BP, followed by ExSBP low , then ExSBP max . We also repeated these analyses per 1-SD increment in BP (data not shown) and found consistent results (ie, that the strength of association was strongest for rest BP followed by Bruce stage 2 BP and then maximal exercise BP). With further adjustment for diabetes mellitus, lipids, smoking, body mass index, and family history, HRs were somewhat attenuated but remained significant at the highest quartiles (adjusted HR, 1.88; 95% confidence interval [CI], 1.23 to 2.87 for ExSBP low Ͼ180 mm Hg; and 1.66; 95% CI, 1.14 to 2.40 for ExSBP max Ͼ200 mm Hg).
When exercise capacity was added to the models (not shown), the HR for ExSBP low was further attenuated (1.52; 95% CI, 0.98 to 2.36 for ExSBP low Ͼ180 mm Hg) but remained unchanged for ExSBP max (1.65; 95% CI, 1.13 to 2.40 for ExSBP max Ͼ200 mm Hg). Additional adjustment for exercise-induced ST-segment ischemic changes, chest pain terminating the test, and achievement of target heart rate did not significantly change these results.
Exercise Diastolic BP
Analyses were also performed for diastolic BP measured at rest, ExDBP low , and ExDBP max (Table 3 ). In age-and sex-adjusted as well as multivariate-adjusted analyses, ExDBP low Ͼ90 mm Hg and ExDBP max Ͼ95 mm Hg were significantly associated with CVD death. On the basis of the HRs per 5 mm Hg-increments in diastolic BP, the magnitude of association was stronger for rest diastolic BP, followed by ExDBP low , then ExDBP max ; these results were similar when analyses were repeated per 1-SD increments (not shown). After adjustment for non-BP variables, corresponding HRs for ExDBP low Ͼ90 mm Hg and ExDBP max Ͼ95 mm Hg were 1.63 (95% CI, 1.14 to 2.32) and 1.40 (95% CI, 1.08 to 1.81), respectively. With further adjustment for exercise capacity, the HRs were not changed substantially (1.60; 95% CI, 1.12 to 2.29; and 1.42; 95% CI, 1.10 to 1.83, respectively; not shown).
When rest systolic and diastolic BP were added to the multivariate models, neither exercise systolic nor diastolic BP attained at any level of exercise was significantly associated with CVD death in the population as a whole.
Exercise BP in Nonhypertensive Individuals
Because ExSBP low and ExDBP low were the strongest exercise BP variables associated with CVD death, further analyses at Bruce stage 2 exercise were performed across prespecified subcategories of baseline BP. When we examined only nonhypertensive individuals (untreated baseline BP Ͻ140/ 90 mm Hg), Bruce stage 2 BP Ͼ180/90 mm Hg was associated with a significant 1.5-to 2-fold increased risk of CVD death (Table 4) . Importantly, with further adjustment for rest BP, baseline nonhypertensive participants continued to have significantly higher risk of CVD death associated with ExSBP low Ͼ180 versus Յ180 mm Hg (adjusted HR, 1.81; 95% CI, 1.28 to 2.55; Pϭ0.001).
Participants With Normal BP
Furthermore, the subcategory of nonhypertensive individuals with normal BP (Ͻ120/80 mm Hg) and ExSBP low Ͼ180 versus Յ180 mm Hg saw the greatest increase in risk of CVD 
Tests for Interactions
Statistically significant interactions were seen between baseline BP and exercise systolic BP in relation to CVD death. There was significant interaction between baseline BP categorized as hypertension/nonhypertension and ExSBP low Ͼ180 versus Յ180 mm Hg for CVD death (P interaction ϭ0.03). Similarly, significant interaction was seen when baseline BP was categorized as normal BP/prehypertension/hypertension. No significant interactions were noted for exercise diastolic BP.
Incremental Value of Bruce Stage 2 Exercise BP Over Baseline BP and Risk Factors
Finally, we compared measures of model discrimination, goodness of fit, and reclassification ( 
Discussion
In this prospective North American cohort of asymptomatic individuals followed for 20 years, we found that BP measured at rest, at Bruce stage 2, and during exercise were all significantly associated with CVD death independent of non-BP risk factors. The association was strongest for rest BP, followed by Bruce stage 2 BP, then maximal BP attained during exercise. Further analysis revealed that exercise BP was no longer significant after accounting for rest BP overall. However, baseline hypertension status modified the risk associated with exercise BP. Specifically, among nonhypertensives with either normal BP or prehypertension at rest, elevated exercise BP at Bruce stage 2 Ͼ180/90 mm Hg identified individuals with up to 2.4-fold higher risk of future CVD death and added predictive value to rest BP and risk factors, possibly warranting more aggressive treatment than is currently recommended. Prior studies were mixed regarding the independent association of exercise BP and CVD death. Fagard and colleagues 4 demonstrated that BP attained at submaximal or maximal workloads was not predictive of future CVD death once the model controlled for baseline BP. Although their study population was small and included only baseline hypertensive participants, these findings are in accordance with the present study, which included a larger and healthier baseline population.
The idea that systolic exercise BP independently predicts CVD death came from 2 studies from the early 1990s. Filipovsky and colleagues 6 studied nearly 5000 subjects and found an association between submaximal exercise systolic BP and death after controlling for baseline BP. However, they did not find an association between baseline hypertension and CVD death. Mundal and colleagues 7 examined Ͼ2000 subjects and found that submaximal exercise systolic BP was significantly related to CVD death independent of baseline BP. However, levels of significance diminished once baseline BP was added to the model, consistent with our findings and suggesting that the relative contribution of baseline BP may have been underestimated when initially reported.
Our study additionally extends the knowledge of exercise diastolic BP and its association with CVD death. Until recently, there have been correlative findings between exercise diastolic BP and cholesterol levels and insulin resistance 17 but little on its capability to predict death. The Framingham Offspring Study recently noted an association between low-level exercise diastolic BP and CVD events. 8 The present study suggests that both Bruce stage 2 and maximum diastolic BP predict future CVD death. However, like its systolic counterpart, the predictive capability of diastolic BP during exercise is attenuated once rest BP is added to the model. Interestingly, we found that baseline hypertension status significantly modified the risk associated with exercise BP. that Ϸ25% to 35% of the US population Ն20 years of age has prehypertension, including Ͼ32 million men and Ͼ25 million women. 18 Increased CVD, 19 thickening of the carotid intima and media, 20 and diastolic ventricular dysfunction 21 have been demonstrated in prehypertensive individuals, including those with BP as low as 115/75 mm Hg. 22 Recent work noted increased CVD events in prehypertensives across the age spectrum 23 and, consistent with our own findings, in the prehypertensive group with BP 130 to 139/85 to 89 mm Hg. 24, 25 Because there is little evidence regarding pharmacological treatment and outcomes in this population, current treatment recommendations are lifestyle modifications.
There are potential limitations to the present study. Despite participant recruitment in various geographic sites from a large range of socioeconomic and occupational populations, Ͼ95% of participants were white. Additionally, Ϸ40% of the study population was recruited on the basis of lipid abnormalities. However, similar Framingham Risk Scores and death rates were reported previously in populations less saturated with lipid abnormalities, with no significant interaction between high LDL cholesterol and death. 26 The exercise test protocol was a submaximal Bruce protocol, with termination at Ն90% of maximum predicted heart rate. It remains to be seen whether our results would be applicable to other exercise test protocols and whether results would change if participants were allowed to exercise to exhaustion. Additionally, our primary study end point was CVD death, a hard end point, and it is unclear whether similar results would be noted for nonfatal "softer" cardiovascular events, such as angina or nonfatal myocardial infarction.
In conclusion, rest BP, low-level (Bruce stage 2) exercise BP, and maximum exercise BP were associated with higher CVD death. Exercise-related BP, regardless of workload, was not significant after accounting for rest BP in the overall population. However, baseline hypertension status significantly modified the risk associated with exercise BP. Among nonhypertensives with either normal BP or prehypertension, Bruce stage 2 BP Ͼ180/ 90 mm Hg identified those at significantly higher risk of CVD death and added predictive value to rest BP and other risk factors, a finding that may warrant more aggressive treatment in those individuals than is currently recommended.
